AKA BRANDS HOLDING CORP (AKA)

US00152K2006 - Common Stock

25.02  -0.16 (-0.64%)

Fundamental Rating

3

Overall AKA gets a fundamental rating of 3 out of 10. We evaluated AKA against 122 industry peers in the Specialty Retail industry. AKA may be in some trouble as it scores bad on both profitability and health. AKA is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year AKA has reported negative net income.
In the past year AKA had a positive cash flow from operations.
In multiple years AKA reported negative net income over the last 5 years.
Of the past 5 years AKA 4 years had a positive operating cash flow.

1.2 Ratios

AKA has a worse Return On Assets (-24.56%) than 85.00% of its industry peers.
Looking at the Return On Equity, with a value of -69.91%, AKA is doing worse than 73.33% of the companies in the same industry.
Industry RankSector Rank
ROA -24.56%
ROE -69.91%
ROIC N/A
ROA(3y)-20.96%
ROA(5y)-10.87%
ROE(3y)-46.46%
ROE(5y)-25.39%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 55.10%, AKA belongs to the top of the industry, outperforming 85.83% of the companies in the same industry.
In the last couple of years the Gross Margin of AKA has declined.
The Profit Margin and Operating Margin are not available for AKA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.08%
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

AKA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AKA has less shares outstanding
The debt/assets ratio for AKA has been reduced compared to a year ago.

2.2 Solvency

AKA has an Altman-Z score of 1.12. This is a bad value and indicates that AKA is not financially healthy and even has some risk of bankruptcy.
AKA's Altman-Z score of 1.12 is on the low side compared to the rest of the industry. AKA is outperformed by 75.00% of its industry peers.
The Debt to FCF ratio of AKA is 6.34, which is on the high side as it means it would take AKA, 6.34 years of fcf income to pay off all of its debts.
AKA has a Debt to FCF ratio of 6.34. This is comparable to the rest of the industry: AKA outperforms 54.17% of its industry peers.
AKA has a Debt/Equity ratio of 0.74. This is a neutral value indicating AKA is somewhat dependend on debt financing.
AKA has a Debt to Equity ratio (0.74) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 6.34
Altman-Z 1.12
ROIC/WACCN/A
WACC10.05%

2.3 Liquidity

AKA has a Current Ratio of 1.55. This is a normal value and indicates that AKA is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of AKA (1.55) is better than 60.83% of its industry peers.
AKA has a Quick Ratio of 1.55. This is a bad value and indicates that AKA is not financially healthy enough and could expect problems in meeting its short term obligations.
AKA has a Quick ratio of 0.48. This is comparable to the rest of the industry: AKA outperforms 47.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 0.48

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 85.40% over the past year.
AKA shows a decrease in Revenue. In the last year, the revenue decreased by -1.05%.
Measured over the past years, AKA shows a very strong growth in Revenue. The Revenue has been growing by 36.26% on average per year.
EPS 1Y (TTM)85.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.17%
Revenue 1Y (TTM)-1.05%
Revenue growth 3Y36.26%
Revenue growth 5YN/A
Sales Q2Q%9.49%

3.2 Future

AKA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.39% yearly.
The Revenue is expected to grow by 4.42% on average over the next years.
EPS Next Y43.75%
EPS Next 2Y29.83%
EPS Next 3Y25.39%
EPS Next 5YN/A
Revenue Next Year1.76%
Revenue Next 2Y2.8%
Revenue Next 3Y2.24%
Revenue Next 5Y4.42%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

AKA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AKA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

AKA's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. AKA is more expensive than 66.67% of the companies in the same industry.
AKA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AKA is cheaper than 72.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.64
EV/EBITDA 70.73

4.3 Compensation for Growth

A more expensive valuation may be justified as AKA's earnings are expected to grow with 25.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.83%
EPS Next 3Y25.39%

More info and screens

0

5. Dividend

5.1 Amount

AKA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AKA BRANDS HOLDING CORP

NYSE:AKA (10/29/2024, 8:04:00 PM)

25.02

-0.16 (-0.64%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap263.71M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.56%
ROE -69.91%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 55.11%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.43
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.55
Quick Ratio 0.48
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)85.4%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y43.75%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.05%
Revenue growth 3Y36.26%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y